Neurocrine Bioscience buy UBS Group AG
Start price
06.05.25
/
50%
€108.15
Target price
06.05.26
€134.58
Performance (%)
4.67%
Price
17.04.26
€113.20
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 4.67%. This prediction currently runs until 06.05.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 2.956% | 2.956% |
| iShares Core DAX® | 3,59 % | 3,93 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % |
| iShares S&P 500 | 4,14 % | 4,04 % |
Comments by UBS_Group_AG for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at UBS Group AG from $137.00 to $152.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by UBS_Group_AG for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€115.20
23.01.26
23.01.26
€151.53
23.01.27
23.01.27
-1.74%
17.04.26
17.04.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€119.80
09.10.25
09.10.25
€167.52
09.10.26
09.10.26
-5.51%
17.04.26
17.04.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€113.95
09.07.25
09.07.25
€148.44
09.07.26
09.07.26
-0.66%
17.04.26
17.04.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€86.72
04.04.25
04.04.25
€123.79
04.04.26
04.04.26
31.00%
05.04.26
05.04.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€135.00
08.01.25
08.01.25
€157.20
08.01.26
08.01.26
-14.59%
09.01.26
09.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.45
28.05.24
28.05.24
€177.37
28.05.25
28.05.25
-13.52%
29.05.25
29.05.25